Analyst Expectations For Agilon Health's Future
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed evaluations for Agilon Health (NYSE:AGL) over the past three months, with a range of ratings from bullish to bearish. The average 12-month price target has decreased by 29.08% to $6.83. Recent analyst actions include both raises and lowers in ratings and price targets, reflecting varied perceptions of the company's market standing.
May 24, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Analysts have mixed views on Agilon Health, with recent ratings showing a range from bullish to bearish. The average 12-month price target has decreased by 29.08% to $6.83, indicating a downward trend in expectations.
The decrease in the average 12-month price target by 29.08% and the mixed ratings from analysts suggest a negative short-term outlook for Agilon Health. The varied ratings, including several downgrades, indicate concerns about the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100